UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

~~WASHINGTON~~Washington, D.C. ~~20549~~

FORM 8-K

CURRENT REPORT

~~Pursuant~~PURSUANT toTO ~~Section~~SECTION 13 orOR 15(d) ofOF ~~the Securities Exchange Act of 1934~~ THE

~~Date~~SECURITIES ofEXCHANGE ~~Report~~ACT ~~(Date~~OF ~~of earliest event reported): July 12, 2022~~1934

~~GLOBAL~~Date of ~~WHOLEHEALTH~~Report ~~PARTNERS~~(Date ~~CORPORATION~~of earliest event reported): October 17, 2022

Global WholeHealth Partners Corporation

(Exact name of registrant as specified in its charter)

Nevada		000-56035		46-2316220
(State or other jurisdiction of incorporation)		(Commission File Number)		(IRS Employer Identification No.)

1402 N. El Camino Real San Clemente, CA		92672
000-56035		46-2316220
(Address of Principal Executive Offices)		(Zip Code)
(Commission File Number)		(IRS Employer Identification Number)

Registrant's telephone number, including area code (714) 392-9752

15 Crooked Stick Drive

Newport Beach, California

92660

(Address of Principal Executive Offices)

(Zip Code)

~~N/A~~ (~~Former name or former address, if changed since last report.~~714) 392-9752

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 ~~CFR 240~~CFR240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 ~~CFR 240~~CFR240.13e-4(c))

~~Indicate~~Securities byregistered ~~check~~pursuant ~~mark~~to ~~whether~~Section ~~the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933~~ 12(~~§230.405 of this chapter~~b) ~~or Rule 12b-2~~ of the ~~Securities Exchange~~ Act ~~of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐~~:

Title of Each Class		Trading Symbol(s)		Name of Each Exchange on Which Registered
None		N/A		N/A

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

~~SECTION~~Item 54.02 Non-Reliance ~~CORPORATE~~on ~~GOVERNANCE~~Previously ~~AND~~Issued ~~MANAGEMENT~~Financial Statements or a Related Audit Report or Completed Interim Review.

~~Item~~On ~~5.02.~~October ~~Departure~~17, of2022, ~~Directors~~Global orWholeHealth ~~Certain~~Partners ~~Officers;~~Corporation ~~Election~~(the of“Company”) ~~Directors;~~filed ~~Appointment~~its ofAnnual ~~Certain~~Report ~~Officers;~~on ~~Compensatory~~Form ~~Arrangements~~10-K offor the period ~~Certain~~ended ~~Officers~~June 30, 2022 (the “10-K”).

OnThe ~~July~~10-K ~~12,~~included ~~2022,~~ the ~~Company~~report ~~accepted~~ (the ~~resignation~~“Draft Report”) of ~~Charles~~the ~~Strongo~~Company’s asIndependent ~~Chairman~~Registered ofPublic ~~Board~~Accounting ~~of Directors~~Firm, ~~Chief~~BF ~~Executive Officer, Treasurer~~Borgers ~~and~~CPA ~~Secretary~~PC ~~effective~~(“Borgers ~~July 12~~CPA”), ~~2022.~~on ~~Mr. Strongo communicated to~~ the ~~Company~~financial ~~that~~statements ~~his~~of ~~decision to resign his position with~~ the Company ~~was~~ ~~personal~~for ~~and not caused by a disagreement with~~ the ~~Company~~years onended ~~any~~June ~~matter~~30, ~~relating~~2022 toand ~~the Company’s operations~~2021, ~~policies or~~appearing ~~practices. Mr.~~in ~~Strongo has been a valuable contributor to~~ the ~~Company and will remain as a consultant~~10-K.

On ~~July~~October 2718, 2022, toBorgers ~~fill~~CPA notified (the ~~vacancies~~“Notification”) ~~created~~the byCompany ~~Mr.~~that ~~Strongo’s resignations~~ the ~~Company~~Draft ~~appointed~~Report ~~Mr.~~had F.been ~~Rene~~included ~~Alvarez,~~in ~~Jr.~~the as10-K without the ~~Company’s~~ ~~Chief~~prior ~~Executive~~consent ~~Officer,~~of ~~Secretary,~~Borgers CPA and ~~Treasurer~~that ~~while~~the ~~continuing~~10-K tohad ~~serve~~been asfiled ~~President~~prior ~~and~~to ~~member of~~ the ~~Board~~final approval of ~~Directors. The~~Borgers ~~Company also appointed Mr~~CPA. ~~Edgar~~Management B.held discussions ~~Gonzalez~~with asBorgers ~~Executive~~CPA ~~Vice~~about ~~President~~these matters and asthe aCompany’s ~~member~~Board of ~~the~~Directors ~~Board~~was advised of ~~Directors~~ such discussions.

In light of the existing circumstances, including the Company’s having received the Notification from Borgers CPA, on November 5, 2022, the Company’s Board of Directors determined that the financial statements for the years ended June 30, 2022 and 2021, including the Draft Report, included in the 10-K should no longer be relied upon.

The Company will, upon receipt of Borgers CPA’s final report (the “Definitive Report”) on the Company’s financial statements for the years ended June 30, 2022 and 2021, file an amended Annual Report on Form 10-K (the “Amended 10-K”) that includes the Definitive Report on the Company’s financial statements for the years ended June 30 2022 and 2021. The Company will file the Amended 10-K as soon as is practicable.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the ~~registrant~~Registrant has duly caused this report to be signed on its behalf by the undersigned, ~~hereunto~~hereunder duly authorized.

	GLOBAL WHOLEHEALTH PARTNERS CORPORATION (Registrant)
	GLOBAL WHOLEHEALTH PARTNERS CORPORATION
Date: August 15, 2022	By:	/s/ F. Rene Alvarez, Jr.
Dated: November 7, 2022.	By:	/s/ F. Rene Alvarez, Jr.
	~~F. Rene Alvarez, Jr.~~	F. Rene Alvarez, Jr.
	~~President~~	President

Filing Compare · Global Wholehealth Partners Corp